Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：128 Table Number：142
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Cancer Drugs market in this environment. In terms of revenue, this research report indicated that the global Cancer Drugs market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Cancer Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Roche aims at producing XX K Units Cancer Drugs in 2020, with XX % production to take place in global market, Novartis accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Cancer Drugs Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Cancer Drugs Market? Roche Novartis Celgene Bristol-Myers Squibb Amgen Johnson & Johnson Pfizer Takeda Eli Lilly AstraZeneca Astellas Merck & Co. Sanofi Bayer Biogen Idec Eisai Teva Otsuka Merck KGaA Ipsen AbbVie Gilead Sciences ... Major Type of Cancer Drugs Covered in XYZResearch report: Chemotherapy Targeted Therapy Immunotherapy Hormonal Therapy (Biologic Therapy) Others Application Segments Covered in XYZResearch Market Blood Cancer Breast Cancer Gastrointestinal Cancer Prostate Cancer Respiratory/Lung Cancer Other Cancers For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Cancer Drugs Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Chemotherapy -Product Introduction and Major Manufacturers 1.1.2 Targeted Therapy -Product Introduction and Major Manufacturers 1.1.3 Immunotherapy -Product Introduction and Major Manufacturers 1.1.4 Hormonal Therapy (Biologic Therapy) -Product Introduction and Major Manufacturers 1.1.5 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Cancer Drugs Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Cancer Drugs Market 3.1.1 Top Companies leading Cancer Drugs Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Cancer Drugs Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Cancer Drugs Market 3.2.1 Top Companies leading Cancer Drugs Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Cancer Drugs Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Cancer Drugs Market 3.3.1 Top Companies leading Cancer Drugs Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Cancer Drugs Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Cancer Drugs Market 3.4.1 Top Companies leading Cancer Drugs Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Cancer Drugs Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Cancer Drugs Market 3.5.1 Top Companies leading Cancer Drugs Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Cancer Drugs Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Cancer Drugs Market 3.6.1 Top Companies leading Cancer Drugs Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Cancer Drugs Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Cancer Drugs Market 3.7.1 Top Companies leading Cancer Drugs Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Cancer Drugs Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Cancer Drugs Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Cancer Drugs Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Cancer Drugs Sales and Growth Rate (2021-2027) 5.2 Global Cancer Drugs Sales Value and Growth Rate (2021-2027) 6 Cancer Drugs Competitive Analysis 6.1 Roche 6.1.1 Roche Company Profiles 6.1.2 Roche Product Introduction 6.1.3 Roche Cancer Drugs Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Novartis 6.2.1 Novartis Company Profiles 6.2.2 Novartis Product Introduction 6.2.3 Novartis Cancer Drugs Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Celgene 6.3.1 Celgene Company Profiles 6.3.2 Celgene Product Introduction 6.3.3 Celgene Cancer Drugs Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Bristol-Myers Squibb 6.4.1 Bristol-Myers Squibb Company Profiles 6.4.2 Bristol-Myers Squibb Product Introduction 6.4.3 Bristol-Myers Squibb Cancer Drugs Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Amgen 6.5.1 Amgen Company Profiles 6.5.2 Amgen Product Introduction 6.5.3 Amgen Cancer Drugs Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Johnson & Johnson 6.6.1 Johnson & Johnson Company Profiles 6.6.2 Johnson & Johnson Product Introduction 6.6.3 Johnson & Johnson Cancer Drugs Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Pfizer 6.7.1 Pfizer Company Profiles 6.7.2 Pfizer Product Introduction 6.7.3 Pfizer Cancer Drugs Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Takeda 6.8.1 Takeda Company Profiles 6.8.2 Takeda Product Introduction 6.8.3 Takeda Cancer Drugs Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 Eli Lilly 6.9.1 Eli Lilly Company Profiles 6.9.2 Eli Lilly Product Introduction 6.9.3 Eli Lilly Cancer Drugs Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 6.10 AstraZeneca 6.10.1 AstraZeneca Company Profiles 6.10.2 AstraZeneca Product Introduction 6.10.3 AstraZeneca Cancer Drugs Production, Revenue (2016-2021) 6.10.4 SWOT Analysis 6.11 Astellas 6.12 Merck & Co. 6.13 Sanofi 6.14 Bayer 6.15 Biogen Idec 6.16 Eisai 6.17 Teva 6.18 Otsuka 6.19 Merck KGaA 6.20 Ipsen 6.21 AbbVie 6.22 Gilead Sciences 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Cancer Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Cancer Drugs Sales (K Unit) by Type (2026-2027) Figure Global Cancer Drugs Sales (K Unit) and Growth Rate (2026-2027) Figure Global Cancer Drugs Sales Market Share (%) by Type (2019 -2020) Table Global Cancer Drugs Sales Value (Million USD) by Type (2026-2027) Figure Global Cancer Drugs Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Cancer Drugs Sales Value Market Share (%) by Type (2019-2020) Table Global Cancer Drugs Sales (K Unit) by Application (2026-2027) Table China Cancer Drugs Sales (K Unit) of Major Company (2016-2021) Table China Cancer Drugs Sales Market Share of Major Company (2016-2021) Table China Cancer Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure China Cancer Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table China Cancer Drugs Sales Value Share of Major Company (2016-2021) Table China Cancer Drugs Price (USD/Unit), by Type (2019-2020) Table China Cancer Drugs Sales (Unit) by Type (2026-2027) Figure China Cancer Drugs Sales (Unit) by Type (2026-2027) Table EU Cancer Drugs Sales (K Unit) of Major Company (2016-2021) Table EU Cancer Drugs Sales Market Share of Major Company (2016-2021) Table EU Cancer Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure EU Cancer Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Cancer Drugs Sales Value Share of Major Company (2016-2021) Table EU Cancer Drugs Price (USD/Unit), by Type (2019-2020) Table EU Cancer Drugs Sales (Unit) by Type (2026-2027) Figure EU Cancer Drugs Sales (Unit) by Type (2026-2027) Table USA Cancer Drugs Sales (K Unit) of Major Company (2016-2021) Table USA Cancer Drugs Sales Market Share of Major Company (2016-2021) Table USA Cancer Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure USA Cancer Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Cancer Drugs Sales Value Share of Major Company (2016-2021) Table USA Cancer Drugs Price (USD/Unit), by Type (2019-2020) Table USA Cancer Drugs Sales (Unit) by Type (2026-2027) Figure USA Cancer Drugs Sales (Unit) by Type (2026-2027) Table Japan Cancer Drugs Sales (K Unit) of Major Company (2016-2021) Table Japan Cancer Drugs Sales Market Share of Major Company (2016-2021) Table Japan Cancer Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Cancer Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Cancer Drugs Sales Value Share of Major Company (2016-2021) Table Japan Cancer Drugs Price (USD/Unit), by Type (2019-2020) Table Japan Cancer Drugs Sales (Unit) by Type (2026-2027) Figure Japan Cancer Drugs Sales (Unit) by Type (2026-2027) Table India Cancer Drugs Sales (K Unit) of Major Company (2016-2021) Table India Cancer Drugs Sales Market Share of Major Company (2016-2021) Table India Cancer Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure India Cancer Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table India Cancer Drugs Sales Value Share of Major Company (2016-2021) Table India Cancer Drugs Price (USD/Unit), by Type (2019-2020) Table India Cancer Drugs Sales (Unit) by Type (2026-2027) Figure India Cancer Drugs Sales (Unit) by Type (2026-2027) Table Southeast Asia Cancer Drugs Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Cancer Drugs Sales Market Share of Major Company (2016-2021) Table Southeast Asia Cancer Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Cancer Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Cancer Drugs Sales Value Share of Major Company (2016-2021) Table Southeast Asia Cancer Drugs Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Cancer Drugs Sales (Unit) by Type (2026-2027) Figure Southeast Asia Cancer Drugs Sales (Unit) by Type (2026-2027) Table South America Cancer Drugs Sales (K Unit) of Major Company (2016-2021) Table South America Cancer Drugs Sales Market Share of Major Company (2016-2021) Table South America Cancer Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure South America Cancer Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Cancer Drugs Sales Value Share of Major Company (2016-2021) Table South America Cancer Drugs Price (USD/Unit), by Type (2019-2020) Table South America Cancer Drugs Sales (Unit) by Type (2026-2027) Figure South America Cancer Drugs Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Cancer Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Cancer Drugs Figure Cost Structure of Cancer Drugs in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Cancer Drugs Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Cancer Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Roche Profiles Table Roche Cancer Drugs Product Introduction Table Roche Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Roche SWOT Analysis Table Novartis Profiles Table Novartis Cancer Drugs Product Introduction Table Novartis Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Novartis SWOT Analysis Table Celgene Profiles Table Celgene Cancer Drugs Product Introduction Table Celgene Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Celgene SWOT Analysis Table Bristol-Myers Squibb Profiles Table Bristol-Myers Squibb Cancer Drugs Product Introduction Table Bristol-Myers Squibb Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Bristol-Myers Squibb SWOT Analysis Table Amgen Profiles Table Amgen Cancer Drugs Product Introduction Table Amgen Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Amgen SWOT Analysis Table Johnson & Johnson Profiles Table Johnson & Johnson Cancer Drugs Product Introduction Table Johnson & Johnson Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Johnson & Johnson SWOT Analysis Table Pfizer Profiles Table Pfizer Cancer Drugs Product Introduction Table Pfizer Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Pfizer SWOT Analysis Table Takeda Profiles Table Takeda Cancer Drugs Product Introduction Table Takeda Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Takeda SWOT Analysis Table Eli Lilly Profiles Table Eli Lilly Cancer Drugs Product Introduction Table Eli Lilly Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Eli Lilly SWOT Analysis Table AstraZeneca Profiles Table AstraZeneca Cancer Drugs Product Introduction Table AstraZeneca Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure AstraZeneca SWOT Analysis Table Astellas Profiles Table Astellas Cancer Drugs Product Introduction Table Astellas Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Astellas SWOT Analysis Table Merck & Co. Profiles Table Merck & Co. Cancer Drugs Product Introduction Table Merck & Co. Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Merck & Co. SWOT Analysis Table Sanofi Profiles Table Sanofi Cancer Drugs Product Introduction Table Sanofi Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Sanofi SWOT Analysis Table Bayer Profiles Table Bayer Cancer Drugs Product Introduction Table Bayer Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Bayer SWOT Analysis Table Biogen Idec Profiles Table Biogen Idec Cancer Drugs Product Introduction Table Biogen Idec Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Biogen Idec SWOT Analysis Table Eisai Profiles Table Eisai Cancer Drugs Product Introduction Table Eisai Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Eisai SWOT Analysis Table Teva Profiles Table Teva Cancer Drugs Product Introduction Table Teva Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Teva SWOT Analysis Table Otsuka Profiles Table Otsuka Cancer Drugs Product Introduction Table Otsuka Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Otsuka SWOT Analysis Table Merck KGaA Profiles Table Merck KGaA Cancer Drugs Product Introduction Table Merck KGaA Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Merck KGaA SWOT Analysis Table Ipsen Profiles Table Ipsen Cancer Drugs Product Introduction Table Ipsen Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Ipsen SWOT Analysis Table AbbVie Profiles Table AbbVie Cancer Drugs Product Introduction Table AbbVie Cancer Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure AbbVie SWOT Analysis
